Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.96
-0.54 (-4.00%)
At close: Jul 11, 2025, 4:00 PM
12.60
-0.36 (-2.78%)
After-hours: Jul 11, 2025, 7:52 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $193.80 million as of July 11, 2025.
Market Cap
193.80M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$12.96
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $111.34M to $193.80M, an increase of 74.06%. That is a compound annual growth rate of 326,615.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 193.80M | -4.00% |
| Jul 10, 2025 | 201.88M | -8.72% |
| Jul 9, 2025 | 221.17M | -1.99% |
| Jul 8, 2025 | 225.65M | -1.31% |
| Jul 7, 2025 | 228.64M | -3.78% |
| Jul 3, 2025 | 237.61M | 2.22% |
| Jul 2, 2025 | 232.46M | -3.75% |
| Jul 1, 2025 | 241.50M | 0.06% |
| Jun 30, 2025 | 241.35M | 1.51% |
| Jun 27, 2025 | 237.76M | -5.92% |
| Jun 26, 2025 | 252.72M | -6.11% |
| Jun 25, 2025 | 269.17M | 19.48% |
| Jun 24, 2025 | 225.28M | -1.54% |
| Jun 23, 2025 | 228.79M | 2.00% |
| Jun 20, 2025 | 224.31M | 2.60% |
| Jun 18, 2025 | 218.62M | 10.17% |
| Jun 17, 2025 | 198.44M | 78.22% |
| Jun 16, 2025 | 111.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |